Cargando…

Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study

Although a few studies have investigated the risks of peptic ulcer bleeding (PUB) in cirrhotic patients, large population-based studies on in-hospital and long-term reports on recurrent PUB in a cohort of cirrhotic patients are lacking. This 12-year nationwide cohort study aimed to investigate the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shih-Cheng, Hsu, Chien-Ning, Liang, Chih-Ming, Tai, Wei-Chen, Wu, Cheng-Kun, Shih, Chih-Wei, Ku, Ming-Kun, Yuan, Lan-Ting, Wang, Jiunn-Wei, Tseng, Kuo-Lun, Hung, Tsung-Hsing, Nguang, Seng-Howe, Hsu, Pin-I, Wu, Deng-Chyang, Chuah, Seng-Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233423/ https://www.ncbi.nlm.nih.gov/pubmed/28081567 http://dx.doi.org/10.1371/journal.pone.0168918

Ejemplares similares

The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2016)

Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study
por: Liang, Chih-Ming, et al.
Publicado: (2016)

The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation
por: Wu, Cheng-Kun, et al.
Publicado: (2017)

Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis
por: Yuan, Lan-Ting, et al.
Publicado: (2018)

Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan
por: Nguang, Seng-Howe, et al.
Publicado: (2018)

Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan
por: Hung, Tsung-Hsing, et al.
Publicado: (2017)

Association between Helicobacter pylori eradication and the risk of coronary heart diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2018)

Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease
por: Kuo, Ming-Te, et al.
Publicado: (2015)

The Influential Roles of Antibiotics Prophylaxis in Cirrhotic Patients with Peptic Ulcer Bleeding after Initial Endoscopic Treatments
por: Yang, Shih-Cheng, et al.
Publicado: (2014)

Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis
por: Liang, Chih-Ming, et al.
Publicado: (2012)

Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs
por: Liang, Chih-Ming, et al.
Publicado: (2019)

The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications
por: Yeh, Wen-Shuo, et al.
Publicado: (2019)

An extended 36-week oral esomeprazole improved long-term recurrent peptic ulcer bleeding in patients at high risk of rebleeding
por: Chiang, Hsueh-Chien, et al.
Publicado: (2022)

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Peptic Ulcer Diseases: Genetics, Mechanism, and Therapies
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
por: Chiang, Hung-Hsien, et al.
Publicado: (2019)

A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
por: Tai, Wei-Chen, et al.
Publicado: (2019)

The impact of aspirin on Klebsiella pneumoniae liver abscess in diabetic patients
por: Tai, Chien-Hsiang, et al.
Publicado: (2020)

Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy for Treatment of Choledocholithiasis
por: Wu, Cheng-Kun, et al.
Publicado: (2021)

Outcome of Holiday and Nonholiday Admission Patients with Acute Peptic Ulcer Bleeding: A Real-World Report from Southern Taiwan
por: Wu, Tsung-Chin, et al.
Publicado: (2014)

Pantoprazole for the Treatment of Peptic Ulcer Bleeding and Prevention of Rebleeding
por: van Rensburg, Christo J., et al.
Publicado: (2012)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
por: Hung, Kuo-Tung, et al.
Publicado: (2021)

First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus
por: Yao, Chih-Chien, et al.
Publicado: (2019)

Decreased risk of liver and intrahepatic cancer in non-H. pylori-infected perforated peptic ulcer patients with truncal vagotomy: a nationwide study
por: Wu, Shih-Chi, et al.
Publicado: (2021)

The Outcome of Prophylactic Intravenous Cefazolin and Ceftriaxone in Cirrhotic Patients at Different Clinical Stages of Disease after Endoscopic Interventions for Acute Variceal Hemorrhage
por: Wu, Cheng-Kun, et al.
Publicado: (2013)

The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial
por: Tai, Wei-Chen, et al.
Publicado: (2023)

Rebleeding after Initial Endoscopic Hemostasis in Peptic Ulcer Disease
por: Hong, Mi Jin, et al.
Publicado: (2014)

Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2020)

Prognosis of hypoglycemia episode in cirrhotic patients during hospitalization
por: Hung, Tsung-Hsing, et al.
Publicado: (2021)

Number of endoscopic sessions to eradicate varices identifies high risk of rebleeding in cirrhotic patients
por: Guo, Huiwen, et al.
Publicado: (2022)

Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort study
por: Liu, Chueh-Ling, et al.
Publicado: (2016)

Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance
por: Huang, Tzu-Hsin, et al.
Publicado: (2021)

Update on the second-line treatment of Helicobacter pylori infection: a narrative review
por: Shih, Chih-An, et al.
Publicado: (2023)

Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) Study
por: Kim, Joon Sung, et al.
Publicado: (2018)

High mortality of pneumonia in cirrhotic patients with ascites
por: Hung, Tsung-Hsing, et al.
Publicado: (2013)

A comparative study of risk of pneumonia and mortalities between nasogastric and jejunostomy feeding routes in surgical critically ill patients with perforated peptic ulcer
por: Wu, Shih-Chi, et al.
Publicado: (2019)

High Mortality of Cirrhotic Patients With End-Stage Renal Disease
por: Hung, Tsung-Hsing, et al.
Publicado: (2016)

The long-term outcomes of cirrhotic patients with pleural effusion
por: Hung, Tsung-Hsing, et al.
Publicado: (2018)

CT-Based Radiomics Score Can Accurately Predict Esophageal Variceal Rebleeding in Cirrhotic Patients
por: Meng, Dongxiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_isv8gcds6je73p8clc4m868ss6